vimarsana.com

Latest Breaking News On - Cgi approval - Page 1 : vimarsana.com

DCGI: India s drug approval system is broken but the proposed new law does nothing to fix it

Despite the Drugs Controller General of India having functioned in a whimsical and opaque manner, the draft bill does not curb its vast discretionary powers.

United statesMansukh mandaviyaTribhuban mohapatraUnion healthMohapatra committeeCentral licensing authorityParliamentary committeeEuropean medical agencyAmerican senateCentral bureau of investigationParliamentary standing committee on healthDrug controller generalDrugs controller generalDrugs controllerMedical devices billKefauver harris amendments

ENTOD Pharma receives DCGI approval for phase 3 trials for myopia eye drop

Maharashtra based pharmaceutical company has the highest market share in low dose atropine MYATRO 0.01 per cent eye drops is used to treat eye problems like myopia, especially in children.

United statesNamrata sharmaNikkhilk masurkarEntod pharmaceuticals onAmerican academy of ophthalmologyIndia ophthalmological societyDrug controller generalLow concentration atropineMyopia progressionAmerican academyExecutive directorGeneral secretaryAll india ophthalmological societyDose atropineEntod pharmaCgi approval

Covishield, Covaxin get regular market approval for use in adult population

Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.

V krishna mohanPrakash kumar singhRegulatory affairsBharat biotech international limitedSerum institute of indiaExpert committeeCentral drugs standard control organisationNew drugsClinical trials rulesDrugs controller generalSubject expert committeeSerum instituteBharat biotechKumar singhHyderabad based bharat biotechBiotech international limited

New Drug Molnupiravir Get DCGI Approval, Can It Be the Solution for the Fight Against COVID-19

The Drug Controller General of India (DCGI) has given its nod to Molnupiravir for Emergency Use Authorisation (EUA) for the treatment of adult patients with Covid-19 and who have high risk of progression of the disease.

Drug controller generalEmergency use authorisationCovid 19Cgi approvalOvid 19 casesOmicron variantArs cov 2Ovid 19 infectionDelta variantCovid 19 treatmentDrug controller general of indiaEmergency use authorisationNti viral oral pillHarmaceutical giant merck coMedicines and healthcare products regulatory agencyUs food and drug administration

India reports 38,667 fresh COVID cases in 24 hours, recovery rate stands at 97 45%

According to the data shared by the Union Health Ministry on Friday, the country saw a total of 35,743 discharges in the last 24 hours.

Jammu and kashmirDadra and nagar haveliUttar pradeshMadhya pradeshHimachal pradeshTamil naduAndhra pradeshUnion health ministry onIndian council of medical researchImage sourceUnion health ministryIndian councilMedical researchNagar haveliCovid casesCovid vaccination

vimarsana © 2020. All Rights Reserved.